Osaka Medical College Hospital

Takatsuki, Osaka 5698686

1 studies enrolling now · 7 studies all time

What they study most

Chronic Heart Failure With Preserved Ejection Fraction, Colorectal Cancer, EPP, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Heart Failure, Primary Peritoneal Carcinoma, XLP

Studies at this site

• Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP) — Recruiting now
• Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoietic Protoporphyria or X-Linked Protoporphyria — Completed
• Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies — Completed
• A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal Cancer — Completed
• Intraperitoneal Therapy For Ovarian Cancer With Carboplatin Trial — Completed
• Patient-reported Outcomes in Vericiguat-treated Patients With HFpEF — Completed
• A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Preserved Ejection Fraction — Completed